-
1Academic Journal
المؤلفون: L. N. Mazankova, O. V. Kalyuzhin, N. A. Dracheva, O. I. Klimova, E. R. Samitova, Л. Н. Мазанкова, О. В. Калюжин, Н. А. Драчева, О. И. Климова, Э. Р. Самитова
المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 69, № 2 (2024); 92-100 ; Российский вестник перинатологии и педиатрии; Том 69, № 2 (2024); 92-100 ; 2500-2228 ; 1027-4065
مصطلحات موضوعية: SARS-CoV-2, combined infection, COVID-19, influenza, сочетанная инфекция, грипп
وصف الملف: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/1976/1483; Баранов А.А., Баранов А.А., Лобзин Ю.В., Намазова-Баранова Л.С., Таточенко В.К., Усков А.Н. и др. Острая респираторная вирусная инфекция у детей: современные подходы к диагностике и лечению. Педиатрическая фармакология 2017; 14(2): 100–108.; Nayak J., Hoy G., Gordon A. Influenza in Children. Cold Spring Harb Perspect Med 2021; 11(1): a038430. DOI:10.1101/cshperspect.a038430; Krumbein H., Kümmel L.S., Fragkou P.C., Thölken C., Hünerbein B.L., Reiter R., et al. Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis. Rev Med Virol 2023; 33(1): e2365. DOI:10.1002/rmv.2365; Swets M.C., Russell C.D., Harrison E.M., Docherty A.B., Lone N., Girvan M. et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet 2022; 399(10334): 1463–1464. DOI:10.1016/S0140–6736(22)00383-X; Ozaras R., Cirpin R., Duran A., Duman H., Arslan O., Bakcan Y. et al. Influenza and COVID-19 coinfection: Report of six cases and review of the literature. J Med Virol 2020; 92(11): 2657–2665. DOI:10.1002/jmv.26125; Laris-González A., Avilés-Robles M., Domínguez-Barrera C., Parra-Ortega I., Sánchez-Huerta J.L., Ojeda-Diezbarroso K. et al. Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mex-ico City. Front Pediatr 2021; 9: 676611. DOI:10.3389/fped.2021.676611; Kanji J.N., Zelyas N., Pabbaraju K., Granger D., Wong A., Murphy S.A. et al. Respiratory virus coinfections with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) continue to be rare one year into the coronavirus disease 2019 (COVID-19) pandemic in Alberta, Canada (June 2020–May 2021). Infect Control Hosp Epidemiol 2023: 44(5): 805–808. DOI:10.1017/ice.2021.495; Tang C.Y., Boftsi M., Staudt L., McElroy J.A., Li T., Duong S. et al. SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021–2022 influenza season. Virology 2022; 576: 105–110. DOI:10.1016/j.virol.2022.09.009; Mardani M., Mohammad J. NasiriInfluenza and COVID-19 Co-infection. Arch Clin Infect Dis 2022; 17(3): e131750. DOI:10.5812/archcid-131750; Kim H.K., Kang J.A., Lyoo K.S., Le T.B., Yeo Y.H., Wong S.S. et al. Severe acute respiratory syndrome coronavirus 2 and influenza A virus co-infection alters viral tropism and haematological composition in Syrian hamsters. Transbound Emerg Dis 2022; 69(5): e3297–e3304. DOI:10.1111/tbed.14601; Swets M.C., Russell C.D., Harrison E.M., Docherty A.B., Lone N., Girvan M., et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet 2022; 399: 1463–1464 DOI:10.1016/S0140–6736(22)00383-X; Huang Y., Skarlupka A.L., Jang H., Blas-Machado U., Holladay N., Hogan R.J. et al. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets. J Virol 2022; 96(5): e0179121. DOI:10.1128/JVI.01791–21; Guan Z., Chen C., Li Y., Yan D., Zhang X., Jiang D. et al. Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis. Front Public Health 2021; 9: 773130. DOI:10.3389/fpubh.2021.773130; Alosaimi B., Naeem A., Hamed M.E., Alkadi H.S., Alanazi T., Al Rehily S.S. et al. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virol J 2021; 18(1): 127. DOI:10.1186/s12985–021–01594–0; Konala V.M., Adapa S., Gayam V., Naramala S., Daggubati S.R., Kammari C.B., Chenna A. Co-infection with Influenza A and COVID-19. Eur J Case Rep Intern Med 2020; 7(5): 001656. DOI:10.12890/2020_001656; Yin Z., Kang Z., Yang D., Ding S., Luo H., Xiao E. A comparison of clinical and chest CT findings in patients with influenza A (H1N1) virus infection and coronavirus disease (COVID-19). Am J Roentgenol 2020; 5: 1065–1071; https://www.ped-perinatology.ru/jour/article/view/1976
-
2Academic Journal
المؤلفون: A. M. Lila, L. I. Alekseeva, I. B. Belyaeva, I. B. Vinogradova, N. A. Demidova, O. V. Kalyuzhin, I. I. Nesterovich, V. N. Sorotskaya, L. Yu. Shirokova, S. P. Yakupova, А. М. Лила, Л. И. Алексеева, И. Б. Беляева, И. Б. Виноградова, Н. А. Демидова, О. В. Калюжин, И. И. Нестерович, В. Н. Сороцкая, Л. Ю. Широкова, С. П. Якупова
المساهمون: Статья спонсируется компанией ООО «НПО Петровакс Фарм».
المصدر: Modern Rheumatology Journal; Том 17, № 6 (2023); 136-142 ; Современная ревматология; Том 17, № 6 (2023); 136-142 ; 2310-158X ; 1996-7012
مصطلحات موضوعية: босвеллиевые кислоты, gonarthrosis, ARTNEO, undenatured (native) type II collagen, oral immune tolerance, boswellic acids, гонартроз, Артнео, неденатурированный (нативный) коллаген II типа, оральная иммунная толерантность
وصف الملف: application/pdf
Relation: https://mrj.ima-press.net/mrj/article/view/1514/1430; Yao Q, Wu X, Tao C, et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct Target Ther. 2023 Feb 3;8(1):56. doi:10.1038/s41392-023-01330-w.; Hawker GA, King LK. The Burden of Osteoarthritis in Older Adults. Clin Geriatr Med. 2022 May;38(2):181-192. doi:10.1016/j.cger.2021.11.005.; Favero M, Belluzzi E, Ortolan A, et al. Erosive hand osteoarthritis: latest findings and outlook. Nat Rev Rheumatol. 2022 Mar;18(3): 171-183. doi:10.1038/s41584-021-00747-3. Epub 2022 Feb 1.; Conaghan PG, Abraham L, Graham-Clarke P, et al. OP0190 Understanding current prescription drug treatment paradigms for patients with osteoarthritis in Europe. Ann Rheum Dis. 2020;79:118.; Namba RS, Inacio MC, Pratt NL, et al. Postoperative opioid use as an early indication of total hip arthroplasty failure. Acta Orthop. 2016 Jul;87 Suppl 1(Suppl 1):37-43. doi:10.1080/17453674.2016.1181820. Epub 2016 May 11.; Conley B, Bunzli S, Bullen J, et al. Core Recommendations for Osteoarthritis Care: A Systematic Review of Clinical Practice Guidelines. Arthritis Care Res (Hoboken). 2023 Sep;75(9):1897-1907. doi:10.1002/acr.25101. Epub 2023 Mar 17.; Резолюция консенсуса экспертов Российской Федерации по диагностике и лечению остеоартрита для врачей первичного звена. Терапия. 2022;8(5):119-128.; Honvo G, Lengele L, Charles A, et al. Role of Collagen Derivatives in Osteoarthritis and Cartilage Repair: A Systematic Scoping Review With Evidence Mapping. Rheumatol Ther. 2020 Dec;7(4):703-740. doi:10.1007/s40744-020-00240-5. Epub 2020 Oct 17.; Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016 Jan 29;15:14. doi:10.1186/s12937-016-0130-8.; Crowley DC, Lau FC, Sharma P, et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. Int J Med Sci. 2009 Oct 9;6(6):312-21. doi:10.7150/ijms.6.312.; Liu X, Machado GC, Eyles JP, et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018 Feb;52(3):167-175. doi:10.1136/bjsports-2016-097333. Epub 2017 Oct 10.; Nagler-Anderson C, Bober LA, Robinson ME, et al. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443-6. doi:10.1073/pnas.83.19.7443.; Milojevic D, Nguyen KD, Wara D, Mellins ED. Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development. Pediatr Rheumatol Online J. 2008 Dec 1:6:20. doi:10.1186/1546-0096-6-20.; Tordesillas L, Berin MC. Mechanisms of Oral Tolerance. Clin Rev Allergy Immunol. 2018 Oct;55(2):107-117. doi:10.1007/s12016-018-8680-5.; Faria AM, Weiner HL. Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol. 2006 Jun-Dec; 13(2-4):143-57. doi:10.1080/17402520600876804.; Bagchi D, Misner B, Bagchi M, et al. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration. Int J Clin Pharmacol Res. 2002;22(3-4):101-10.; Collagenase and rheumatoid arthritis. N Engl J Med. 1968 Oct 24;279(17):942-3. doi:10.1056/NEJM196810242791710.; Mabbott NA, Donaldson DS, Ohno H, et al. Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol. 2013 Jul;6(4):666-77. doi:10.1038/mi.2013.30. Epub 2013 May 22.; Pabst O, Mowat AM. Oral tolerance to food protein. Mucosal Immunol. 2012 May; 5(3):232-9. doi:10.1038/mi.2012.4. Epub 2012 Feb 8.; Wambre E, Jeong D. Oral Tolerance Development and Maintenance. Immunol Allergy Clin North Am. 2018 Feb;38(1):27-37. doi:10.1016/j.iac.2017.09.003. Epub 2017 Oct 26.; Lv Z, Yang YX, Li J, et al. Molecular Classification of Knee Osteoarthritis. Front Cell Dev Biol. 2021 Aug 27;9:725568. doi:10.3389/fcell.2021.725568.; National Academies of Sciences, Engineering, and Medicine. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington: The National Academies Press; 2017.; Mahajan R, Rathod NR, Narayanan V. (2019). Multimodal Anti-Inflammatory Approach to Osteoarthritis Management – Review of T Cell Immunomodulation with Undenatured (Native) Collagen Type II, and LOX Inhibition with Boswellia. Nov Tech Arthritis Bone Res. 2019;3(4):555618. doi:10.19080/NTAB.2019.03.555618.; Zapata A, Fernandez-Parra R. Management of Osteoarthritis and Joint Support Using Feed Supplements: A Scoping Review of Undenatured Type II Collagen and Boswellia serrata. Animals (Basel). 2023 Feb 27;13(5): 870. doi:10.3390/ani13050870.; Jain AV, Jain KA, Vijayaraghavan N. AflaB2® and Osteoarthritis: A Multicentric, Observational, Post-Marketing Surveillance Study in Indian Patients Suffering from Knee Osteoarthritis. Int J Res Orthop. 2021 Jan;7(1): 110-115. doi:10.18203/issn.2455-4510. IntJResOrthop20205570.; Sadigursky D, Sanches M, Garcia N, et al. Effectiveness of the use of non-hydrolysed type II collagen in the treatment of osteoarthritis: a systematic review and meta-analysis. Brazilian Journal of Health Review. 2023; 6(1):1649-1660. doi:10.34119/bjhrv6n1-131.; Yu G, Xiang W, Zhang T, et al. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complement Med Ther. 2020 Jul 17;20(1):225. doi:10.1186/s12906-020-02985-6.; Cameron M, Chrubasik S. Oral herbal therapies for treating osteoarthritis. Cochrane Database Syst Rev. 2014 May 22;2014(5): CD002947. doi:10.1002/14651858. CD002947.pub2.; Gwinnutt JM, Wieczorek M, Rodriguez-Carrio J, et al. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. RMD Open. 2022 Jun; 8(2):e002167. doi:10.1136/rmdopen-2021-002167.; Neogi T, Colloca L. Placebo effects in osteoarthritis: implications for treatment and drug development. Nat Rev Rheumatol. 2023 Oct;19(10):613-626. doi:10.1038/s41584- 023-01021-4. Epub 2023 Sep 11.; Wen X, Luo J, Mai Y, et al. Placebo Response to Oral Administration in Osteoarthritis Clinical Trials and Its Associated Factors: A Model-Based Meta-analysis. JAMA Netw Open. 2022 Oct 3;5(10):e2235060. doi:10.1001/jamanetworkopen.2022.35060.; Lane NE, Hochberg MC, Nevitt MC, et al. OARSI clinical trials recommendations: design and conduct of clinical trials for hip osteoarthritis. Osteoarthritis Cartilage. 2015 May;23(5):761-71. doi:10.1016/j.joca.2015.03.006.; https://mrj.ima-press.net/mrj/article/view/1514
-
3Academic Journal
المؤلفون: O. V. Kalyuzhin, L. O. Ponezheva, A. N. Turapova, A. Yu. Nurtazina, A. S. Bykov, A. V. Karaulov, О. В. Калюжин, Л. О. Понежева, А. Н. Турапова, А. Ю. Нуртазина, А. С. Быков, А. В. Караулов
المصدر: Bulletin of Siberian Medicine; Том 21, № 2 (2022); 48-59 ; Бюллетень сибирской медицины; Том 21, № 2 (2022); 48-59 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2022-21-2
مصطلحات موضوعية: иммунный ответ 1-го типа, interferon gamma, interferon alpha-2b, antioxidants, pidotimod, tilorone, interferon receptors, type 1 immune responses, интерферон гамма, интерферон альфа-2b, антиоксиданты, пидотимод, тилорон, рецепторы интерферонов
وصف الملف: application/pdf
Relation: https://bulletin.tomsk.ru/jour/article/view/4811/3201; Gentile D.A., Fireman P., Skoner D.P. Elevations of local leukotriene C4 levels during viral upper respiratory tract infections. Ann. Allergy Asthma Immunol. 2003;91(3):270–274. DOI:10.1016/S1081-1206(10)63529-6.; Graham A.C., Temple R.M., Obar J.J. Mast cells and influenza a virus: association with allergic responses and beyond. Front. Immunol. 2015;6:238. DOI:10.3389/fimmu.2015.00238.; Nijkamp F.P., Sitsen J.M. Leukotrienes, allergy and inflammation. Pharm. Weekbl. Sci. 1982;4(6):165–171. DOI:10.1007/BF01959134.; Skoner D.P., Gentile D.A., Fireman P., Cordoro K., Doyle W.J. Urinary histamine metabolite elevations during experimental influenza infection. Ann. Allergy Asthma Immunol. 2001;87(4):303–306. DOI:10.1016/s1081-1206(10)62244-2.; Ricciotti E., FitzGerald G.A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 2011;31(5):986–1000. DOI:10.1161/ATVBAHA.110.207449.; Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol. Rev. 2017;278(1):162–172. DOI:10.1111/imr.12557.; Scadding G.K., Scadding G.W. Innate and adaptive immunity: ILC2 and Th2 cells in upper and lower airway allergic diseases. J. Allergy Clin. Immunol. Pract. 2021;9(5):1851–1857. DOI:10.1016/j.jaip.2021.02.013.; Norlander A.E., Peebles R.S. Jr. Innate type 2 responses to respiratory syncytial virus infection. Viruses. 2020;12(5):521. DOI:10.3390/v12050521.; Rajput C., Han M., Ishikawa T., Lei J., Goldsmith A.M., Jazaeri S. et al. Rhinovirus C infection induces type 2 innate lymphoid cell expansion and eosinophilic airway inflammation. Front. Immunol. 2021;12:649520. DOI:10.3389/fimmu.2021.649520.; Basnet S., Palmenberg A.C., Gern J.E. Rhinoviruses and their receptors. Chest. 2019;155(5):1018–1025. DOI:10.1016/j.chest.2018.12.012.; Wang S.Z., Ma F.M., Zhao J.D. Expressions of nuclear factor-kappa B p50 and p65 and their significance in the up-regulation of intercellular cell adhesion molecule-1 mRNA in the nasal mucosa of allergic rhinitis patients. Eur. Arch. Otorhinolaryngol. 2013;270(4):1329–1334. DOI:10.1007/s00405-012-2136-y.; Wegner C.D., Gundel R.H., Reilly P., Haynes N., Letts L.G., Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science. 1990;247(4941):456– 459. DOI:10.1126/science.1967851.; Papi A., Johnston S.L. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J. Biol. Chem. 1999;274(14):9707–9720. DOI:10.1074/jbc.274.14.9707.; Zhou B., Niu W., Liu F., Yuan Y., Wang K., Zhang J. et al. Risk factors for recurrent respiratory tract infection in preschool-aged children. Pediatr. Res. 2021;90(1):223–231. DOI:10.1038/s41390-020-01233-4.; Canonica G.W., Compalati E. Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin. Exp. Immunol. 2009;158(3):260–271. DOI:10.1111/j.1365-2249.2009.04017.x.; Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004;75(2):163–189. DOI:10.1189/jlb.0603252.; Brinkmann V., Geiger T., Alkan S., Heusser C.H. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J. Exp. Med. 1993;178(5):1655–1663. DOI:10.1084/jem.178.5.1655.; Wenner C.A., Güler M.L., Macatonia S.E., O’Garra A., Murphy K.M. Roles of IFN-gamma and IFN-alpha in IL12-induced T helper cell-1 development. J. Immunol. 1996;156(4):1442–1447.; Niu H., Wang R., Jia Y.T., Cai Y. Pidotimod, an immunostimulant in pediatric recurrent respiratory tract infections: A meta-analysis of randomized controlled trials. Int. Immunopharmacol. 2019;67:35–45. DOI:10.1016/j.intimp.2018.11.043.; Vargas Correa J.B., Espinosa Morales S., Bolaños Ancona J.C., Farfán Ale J.A. Pidotimod en infección respiratoria recurrente en el niño con rinitis alérgica, asma o ambos padecimientos [Pidotimod in recurring respiratory infection in children with allergic rhinitis, asthma, or both conditions]. Rev. Alerg. Mex. 2002;49(2):27–32. (In Span.).; Ferrario B.E., Garuti S., Braido F., Canonica G.W. Pidotimod: the state of art. Clin. Mol. Allergy. 2015;13(1):8. DOI:10.1186/s12948-015-0012-1.; Manti S., Parisi G.F., Papale M., Leonardi S. Pidotimod in allergic diseases. Minerva Pediatr. 2020;72:358–363. DOI:10.23736/S0026-4946.20.05967-8.; Krueger R.E., Mayer G.D. Tilorone hydrochloride: an orally active antiviral agent. Science. 1970;169:1213–1214. DOI:10.1126/science.169.3951.1213.; Григорян С.С., Исаева Е.И., Бакалов В.В., Осипова Е.А., Бевз А.Ю., Простяков И.В. и др. Амиксин – индукция интерферонов альфа, бета, гамма и лямбда в сыворотке крови и легочной ткани. Русский медицинский журнал. Медицинское обозрение. 2015;2:93–99.; Калюжин О.В., Исаева Е.И., Ветрова Е.Н., Чернышова А.И., Понежева Л.О., Караулов А.В. Влияние тилорона на динамику вирусной нагрузки и содержания интерферонов и интерлейкина-1β в лёгочной ткани и сыворотке крови мышей с экспериментальным гриппом. Бюллетень экспериментальной биологии и медицины. 2021;171(6):724–728. DOI:10.47056/0365-9615-2021-171-6-724-728.; Понежева Л.О., Исаева Е.И., Ветрова Е.Н., Григорян С.С., Чернышова А.И., Калюжин О.В. и др. Влияние тилорона на вирусную нагрузку и баланс цитокинов, отражающих 1-й и 2-й типы иммунного ответа, в легочной ткани мышей с экспериментальным гриппом. Инфекционные болезни в современном мире: эволюция, текущие и будущие угрозы: сборник трудов ХIII ежегодного всероссийского конгресса по инфекционным болезням имени академика В.И. Покровского (24–26 мая 2021 г.; Москва). М.: Медицинское Маркетинговое Агентство, 2021:231.; Григорян С.С., Майоров И.А., Иванова А.М., Ершов Ф.И. Оценка интерферонового статуса по пробам цельной крови. Вопросы вирусологии. 1988;4:433–436.; Калюжин О.В., Понежева Ж.Б., Купченко А.Н., Шувалов А.Н., Гусева Т.С., Паршина О.В. и др. Клиническая и интерферон-модулирующая эффективность комбинации ректальной и топической форм интерферона-α2b при острых респираторных инфекциях. Терапевтический архив. 2018;90(11):48–54. DOI:10.26442/terarkh201890114-54.; Калюжин О.В., Понежева Ж.Б., Семенова И.В., Хохлова О.Н., Серебровская Л.В., Гусева Т.С. и др. Субпопуляции лимфоцитов, уровень интерферонов и экспрессия их рецепторов у больных хроническими гепатитами В и С: зависимость от вида вирусов и степени фиброза печени. Терапевтический архив. 2017;89(11):14–20. DOI:10.17116/terarkh2017891114-20.; Калюжин О.В. Тилорон как средство выбора для профилактики и лечения острых респираторных вирусных инфекций. Лечащий врач. 2013;10:43–48.; Brindisi G., Zicari A.M., Schiavi L., Gori A., Conte M.P., Marazzato M. et al. Efficacy of Pidotimod use in treating allergic rhinitis in a pediatric population. Ital. J. Pediatr. 2020;46(1):93. DOI:10.1186/s13052-020-00859-8.; Feleszko W., Rossi G.A., Krenke R., Canonica G.W., Van Gerven L., Kalyuzhin O. Immunoactive preparations and regulatory responses in the respiratory tract: potential for clinical application in chronic inflammatory airway diseases. Expert Rev. Respir. Med. 2020;14(6):603–619. DOI:10.1080/17476348.2020.1744436.; Mühl H., Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int. Immunopharmacol. 2003;3(9):1247–1255. DOI:10.1016/S1567-5769(03)00131-0.; Billiau A. Anti-inflammatory properties of type I interferons. Antiviral. Res. 2006;71(2-3):108–116. DOI:10.1016/j.antiviral.2006.03.006.; Kumar K.G., Tang W., Ravindranath A.K., Clark W.A., Croze E., Fuchs S.Y. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J. 2003;22(20):5480–5490. DOI:10.1093/emboj/cdg524.; Thomas C., Moraga I., Levin D., Krutzik P.O., Podoplelova Y., Trejo A. et al. Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell. 2011;146(4):621–32. DOI:10.1016/j.cell.2011.06.048.; Lavoie T.B., Kalie E., Crisafulli-Cabatu S., Abramovich R., DiGioia G., Moolchan K. et al. Binding and activity of all human alpha interferon subtypes. Cytokine. 2011;56(2):282– 289. DOI:10.1016/j.cyto.2011.07.019.; Wilmes S., Beutel O., Li Z., Francois-Newton V., Richter C.P., Janning D. et al. Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling. J. Cell. Biol. 2015;209(4):579–593. DOI:10.1083/jcb.201412049.; Celada A., Schreiber R.D. Internalization and degradation of receptor-bound interferon-gamma by murine macrophages. Demonstration of receptor recycling. J. Immunol. 1987;139(1):147–153.; Crisler W.J., Eshleman E.M., Lenz L.L. Ligand-induced IFNGR1 down-regulation calibrates myeloid cell IFNγ responsiveness. Life Sci. Alliance. 2019;2(5):e201900447. DOI:10.26508/lsa.201900447.; Rayamajhi M., Humann J., Penheiter K., Andreasen K., Lenz L.L. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J. Exp. Med. 2010;207(2):327–337. DOI:10.1084/jem.20091746.; Marijanovic Z., Ragimbeau J., van der Heyden J., Uzé G., Pellegrini S. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem. J. 2007;407(1):141–151. DOI:10.1042/BJ20070605.; https://bulletin.tomsk.ru/jour/article/view/4811